Spondyloarthropathies: Targeted therapy for psoriatic arthritis.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 19412187.
- Also identified by DOI 10.1038/nrrheum.2009.76.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Tumor necrosis factor inhibitors are an effective treatment for psoriatic arthritis, but no single agent is effective in all patients. Novel therapies that target other cytokines have now been tested, with encouraging results.
Medical subject headings
- Antibodies, Monoclonal
- Antirheumatic Agents
- Arthritis, Psoriatic
- Drug Delivery Systems